These were the worst performing ASX 200 shares last week

AMP Ltd (ASX:AMP) and Incitec Pivot Ltd (ASX:IPL) shares were among the worst performers on the ASX 200 last week…

| More on:
A man peers into the camera looking astonished, indicating a rise or drop in ASX share price

Image source: Getty Images

The S&P/ASX 200 Index (ASX: XJO) was in fine form last week and surged notably higher. The benchmark index rose 2.4% over the four days to end the week at 6,995.2 points.

Unfortunately, not all shares on the index were able to climb higher with the market. Here’s why these were the worst performing ASX 200 shares last week:

Chorus Ltd (ASX: CNU)

The Chorus share price was the worst performer on the ASX 200 last week with a 6.4% decline. Investors were selling the New Zealand telco’s shares after it revealed that it has reduced its indicative Maximum Allowable Revenue (MAR) range to NZ$680 million to NZ$710 million. This compares to its previous MAR range of NZ$715 million to NZ$755 million.


The AMP share price was out form and sank 4.9% over the four days. This may have been driven by profit taking after a strong gain a week earlier. That gain was driven by news that the embattled financial services company’s CEO, Francesco De Ferrari, is resigning. Mr De Ferrari will be replaced by the Australia and New Zealand Banking GrpLtd (ASX: ANZ) Deputy CEO, Alexis George. She will join the company in the third quarter of 2021.

Incitec Pivot Ltd (ASX: IPL)

The Incitec Pivot share price wasn’t far behind with a 3.8% decline last week. Investors were selling the agricultural chemicals company’s shares following an update on its Waggaman ammonia operation. Incitec Pivot warned that the operation is expected recommence production later than previously expected. As a result, it expects an earnings before interest and tax (EBIT) impact of $36 million in FY 2021.

Corporate Travel Management Ltd (ASX: CTD)

The Corporate Travel Management share price dropped 3.7% over the four says. This appears to have been driven by concerns over the rollout of COVID-19 vaccines across Australia. This follows the Government’s announcement that under 50s would not be receiving the AstraZeneca vaccine due to blood clotting worries. This has sparked concerns over the timing of the travel market recovery.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Corporate Travel Management Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers